Global Implantable Drug-Eluting Devices Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Implantable Drug-Eluting Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Implantable Drug-Eluting Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Implantable Drug-Eluting Devices market. Implantable Drug-Eluting Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Implantable Drug-Eluting Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Implantable Drug-Eluting Devices market.
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Implantable Drug-Eluting Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Implantable Drug-Eluting Devices market. It may include historical data, market segmentation by Type (e.g., Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Implantable Drug-Eluting Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Implantable Drug-Eluting Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Implantable Drug-Eluting Devices industry. This include advancements in Implantable Drug-Eluting Devices technology, Implantable Drug-Eluting Devices new entrants, Implantable Drug-Eluting Devices new investment, and other innovations that are shaping the future of Implantable Drug-Eluting Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Implantable Drug-Eluting Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Implantable Drug-Eluting Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Implantable Drug-Eluting Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Implantable Drug-Eluting Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Implantable Drug-Eluting Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Implantable Drug-Eluting Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Implantable Drug-Eluting Devices market.
Market Segmentation:
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Implantable Drug-Eluting Devices market?
What factors are driving Implantable Drug-Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Drug-Eluting Devices market opportunities vary by end market size?
How does Implantable Drug-Eluting Devices break out type, application?
According to our LPI (LP Information) latest study, the global Implantable Drug-Eluting Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Implantable Drug-Eluting Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Implantable Drug-Eluting Devices market. Implantable Drug-Eluting Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Implantable Drug-Eluting Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Implantable Drug-Eluting Devices market.
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Implantable Drug-Eluting Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Implantable Drug-Eluting Devices market. It may include historical data, market segmentation by Type (e.g., Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Implantable Drug-Eluting Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Implantable Drug-Eluting Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Implantable Drug-Eluting Devices industry. This include advancements in Implantable Drug-Eluting Devices technology, Implantable Drug-Eluting Devices new entrants, Implantable Drug-Eluting Devices new investment, and other innovations that are shaping the future of Implantable Drug-Eluting Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Implantable Drug-Eluting Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Implantable Drug-Eluting Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Implantable Drug-Eluting Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Implantable Drug-Eluting Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Implantable Drug-Eluting Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Implantable Drug-Eluting Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Implantable Drug-Eluting Devices market.
Market Segmentation:
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Medtronic
- Merck
- Bayer AG
- Johnson & Johnson
- Abbott
- Surmodics
- Boston Scientific Corporation
- Titan Pharmaceuticals, Inc.
- BIOTRONIK
- Allergan
- Bausch & Lomb
- REVA Medical
- MicroPort Medical
What is the 10-year outlook for the global Implantable Drug-Eluting Devices market?
What factors are driving Implantable Drug-Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Drug-Eluting Devices market opportunities vary by end market size?
How does Implantable Drug-Eluting Devices break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Drug-Eluting Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Implantable Drug-Eluting Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Implantable Drug-Eluting Devices by Country/Region, 2019, 2023 & 2030
2.2 Implantable Drug-Eluting Devices Segment by Type
2.2.1 Implantable Drug Infusion Pumps
2.2.2 Intraocular Drug-Eluting Devices
2.2.3 Contraceptive Drug-Eluting Devices
2.2.4 Drug-Eluting Stents
2.2.5 Others
2.3 Implantable Drug-Eluting Devices Sales by Type
2.3.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Implantable Drug-Eluting Devices Sale Price by Type (2019-2024)
2.4 Implantable Drug-Eluting Devices Segment by Application
2.4.1 Diabetes
2.4.2 Contraception
2.4.3 HIV/AIDS Prevention
2.4.4 Chronic Pain Management
2.4.5 Cardiovascular
2.4.6 Ophthalmology
2.4.7 Oncology
2.4.8 Others
2.5 Implantable Drug-Eluting Devices Sales by Application
2.5.1 Global Implantable Drug-Eluting Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Implantable Drug-Eluting Devices Sale Price by Application (2019-2024)
3 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES BY COMPANY
3.1 Global Implantable Drug-Eluting Devices Breakdown Data by Company
3.1.1 Global Implantable Drug-Eluting Devices Annual Sales by Company (2019-2024)
3.1.2 Global Implantable Drug-Eluting Devices Sales Market Share by Company (2019-2024)
3.2 Global Implantable Drug-Eluting Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Implantable Drug-Eluting Devices Revenue by Company (2019-2024)
3.2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
3.3 Global Implantable Drug-Eluting Devices Sale Price by Company
3.4 Key Manufacturers Implantable Drug-Eluting Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Drug-Eluting Devices Product Location Distribution
3.4.2 Players Implantable Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Implantable Drug-Eluting Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Implantable Drug-Eluting Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Implantable Drug-Eluting Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Implantable Drug-Eluting Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Implantable Drug-Eluting Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Implantable Drug-Eluting Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Implantable Drug-Eluting Devices Sales Growth
4.4 APAC Implantable Drug-Eluting Devices Sales Growth
4.5 Europe Implantable Drug-Eluting Devices Sales Growth
4.6 Middle East & Africa Implantable Drug-Eluting Devices Sales Growth
5 AMERICAS
5.1 Americas Implantable Drug-Eluting Devices Sales by Country
5.1.1 Americas Implantable Drug-Eluting Devices Sales by Country (2019-2024)
5.1.2 Americas Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
5.2 Americas Implantable Drug-Eluting Devices Sales by Type
5.3 Americas Implantable Drug-Eluting Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Drug-Eluting Devices Sales by Region
6.1.1 APAC Implantable Drug-Eluting Devices Sales by Region (2019-2024)
6.1.2 APAC Implantable Drug-Eluting Devices Revenue by Region (2019-2024)
6.2 APAC Implantable Drug-Eluting Devices Sales by Type
6.3 APAC Implantable Drug-Eluting Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Drug-Eluting Devices by Country
7.1.1 Europe Implantable Drug-Eluting Devices Sales by Country (2019-2024)
7.1.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
7.2 Europe Implantable Drug-Eluting Devices Sales by Type
7.3 Europe Implantable Drug-Eluting Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Drug-Eluting Devices by Country
8.1.1 Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Implantable Drug-Eluting Devices Sales by Type
8.3 Middle East & Africa Implantable Drug-Eluting Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Drug-Eluting Devices
10.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
10.4 Industry Chain Structure of Implantable Drug-Eluting Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Drug-Eluting Devices Distributors
11.3 Implantable Drug-Eluting Devices Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
12.1 Global Implantable Drug-Eluting Devices Market Size Forecast by Region
12.1.1 Global Implantable Drug-Eluting Devices Forecast by Region (2025-2030)
12.1.2 Global Implantable Drug-Eluting Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Implantable Drug-Eluting Devices Forecast by Type
12.7 Global Implantable Drug-Eluting Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Surmodics
13.7.1 Surmodics Company Information
13.7.2 Surmodics Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Surmodics Main Business Overview
13.7.5 Surmodics Latest Developments
13.8 Boston Scientific Corporation
13.8.1 Boston Scientific Corporation Company Information
13.8.2 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Boston Scientific Corporation Main Business Overview
13.8.5 Boston Scientific Corporation Latest Developments
13.9 Titan Pharmaceuticals, Inc.
13.9.1 Titan Pharmaceuticals, Inc. Company Information
13.9.2 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Titan Pharmaceuticals, Inc. Main Business Overview
13.9.5 Titan Pharmaceuticals, Inc. Latest Developments
13.10 BIOTRONIK
13.10.1 BIOTRONIK Company Information
13.10.2 BIOTRONIK Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BIOTRONIK Main Business Overview
13.10.5 BIOTRONIK Latest Developments
13.11 Allergan
13.11.1 Allergan Company Information
13.11.2 Allergan Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Allergan Main Business Overview
13.11.5 Allergan Latest Developments
13.12 Bausch & Lomb
13.12.1 Bausch & Lomb Company Information
13.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bausch & Lomb Main Business Overview
13.12.5 Bausch & Lomb Latest Developments
13.13 REVA Medical
13.13.1 REVA Medical Company Information
13.13.2 REVA Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 REVA Medical Main Business Overview
13.13.5 REVA Medical Latest Developments
13.14 MicroPort Medical
13.14.1 MicroPort Medical Company Information
13.14.2 MicroPort Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 MicroPort Medical Main Business Overview
13.14.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Drug-Eluting Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Implantable Drug-Eluting Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Implantable Drug-Eluting Devices by Country/Region, 2019, 2023 & 2030
2.2 Implantable Drug-Eluting Devices Segment by Type
2.2.1 Implantable Drug Infusion Pumps
2.2.2 Intraocular Drug-Eluting Devices
2.2.3 Contraceptive Drug-Eluting Devices
2.2.4 Drug-Eluting Stents
2.2.5 Others
2.3 Implantable Drug-Eluting Devices Sales by Type
2.3.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Implantable Drug-Eluting Devices Sale Price by Type (2019-2024)
2.4 Implantable Drug-Eluting Devices Segment by Application
2.4.1 Diabetes
2.4.2 Contraception
2.4.3 HIV/AIDS Prevention
2.4.4 Chronic Pain Management
2.4.5 Cardiovascular
2.4.6 Ophthalmology
2.4.7 Oncology
2.4.8 Others
2.5 Implantable Drug-Eluting Devices Sales by Application
2.5.1 Global Implantable Drug-Eluting Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Implantable Drug-Eluting Devices Sale Price by Application (2019-2024)
3 GLOBAL IMPLANTABLE DRUG-ELUTING DEVICES BY COMPANY
3.1 Global Implantable Drug-Eluting Devices Breakdown Data by Company
3.1.1 Global Implantable Drug-Eluting Devices Annual Sales by Company (2019-2024)
3.1.2 Global Implantable Drug-Eluting Devices Sales Market Share by Company (2019-2024)
3.2 Global Implantable Drug-Eluting Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Implantable Drug-Eluting Devices Revenue by Company (2019-2024)
3.2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
3.3 Global Implantable Drug-Eluting Devices Sale Price by Company
3.4 Key Manufacturers Implantable Drug-Eluting Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Drug-Eluting Devices Product Location Distribution
3.4.2 Players Implantable Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Implantable Drug-Eluting Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Implantable Drug-Eluting Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Implantable Drug-Eluting Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Implantable Drug-Eluting Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Implantable Drug-Eluting Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Implantable Drug-Eluting Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Implantable Drug-Eluting Devices Sales Growth
4.4 APAC Implantable Drug-Eluting Devices Sales Growth
4.5 Europe Implantable Drug-Eluting Devices Sales Growth
4.6 Middle East & Africa Implantable Drug-Eluting Devices Sales Growth
5 AMERICAS
5.1 Americas Implantable Drug-Eluting Devices Sales by Country
5.1.1 Americas Implantable Drug-Eluting Devices Sales by Country (2019-2024)
5.1.2 Americas Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
5.2 Americas Implantable Drug-Eluting Devices Sales by Type
5.3 Americas Implantable Drug-Eluting Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Drug-Eluting Devices Sales by Region
6.1.1 APAC Implantable Drug-Eluting Devices Sales by Region (2019-2024)
6.1.2 APAC Implantable Drug-Eluting Devices Revenue by Region (2019-2024)
6.2 APAC Implantable Drug-Eluting Devices Sales by Type
6.3 APAC Implantable Drug-Eluting Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Drug-Eluting Devices by Country
7.1.1 Europe Implantable Drug-Eluting Devices Sales by Country (2019-2024)
7.1.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
7.2 Europe Implantable Drug-Eluting Devices Sales by Type
7.3 Europe Implantable Drug-Eluting Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Drug-Eluting Devices by Country
8.1.1 Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Implantable Drug-Eluting Devices Sales by Type
8.3 Middle East & Africa Implantable Drug-Eluting Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Drug-Eluting Devices
10.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
10.4 Industry Chain Structure of Implantable Drug-Eluting Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Drug-Eluting Devices Distributors
11.3 Implantable Drug-Eluting Devices Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
12.1 Global Implantable Drug-Eluting Devices Market Size Forecast by Region
12.1.1 Global Implantable Drug-Eluting Devices Forecast by Region (2025-2030)
12.1.2 Global Implantable Drug-Eluting Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Implantable Drug-Eluting Devices Forecast by Type
12.7 Global Implantable Drug-Eluting Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Surmodics
13.7.1 Surmodics Company Information
13.7.2 Surmodics Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Surmodics Main Business Overview
13.7.5 Surmodics Latest Developments
13.8 Boston Scientific Corporation
13.8.1 Boston Scientific Corporation Company Information
13.8.2 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Boston Scientific Corporation Main Business Overview
13.8.5 Boston Scientific Corporation Latest Developments
13.9 Titan Pharmaceuticals, Inc.
13.9.1 Titan Pharmaceuticals, Inc. Company Information
13.9.2 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Titan Pharmaceuticals, Inc. Main Business Overview
13.9.5 Titan Pharmaceuticals, Inc. Latest Developments
13.10 BIOTRONIK
13.10.1 BIOTRONIK Company Information
13.10.2 BIOTRONIK Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BIOTRONIK Main Business Overview
13.10.5 BIOTRONIK Latest Developments
13.11 Allergan
13.11.1 Allergan Company Information
13.11.2 Allergan Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Allergan Main Business Overview
13.11.5 Allergan Latest Developments
13.12 Bausch & Lomb
13.12.1 Bausch & Lomb Company Information
13.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bausch & Lomb Main Business Overview
13.12.5 Bausch & Lomb Latest Developments
13.13 REVA Medical
13.13.1 REVA Medical Company Information
13.13.2 REVA Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 REVA Medical Main Business Overview
13.13.5 REVA Medical Latest Developments
13.14 MicroPort Medical
13.14.1 MicroPort Medical Company Information
13.14.2 MicroPort Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
13.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 MicroPort Medical Main Business Overview
13.14.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Implantable Drug-Eluting Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Implantable Drug-Eluting Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Implantable Drug Infusion Pumps
Table 4. Major Players of Intraocular Drug-Eluting Devices
Table 5. Major Players of Contraceptive Drug-Eluting Devices
Table 6. Major Players of Drug-Eluting Stents
Table 7. Major Players of Others
Table 8. Global Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 9. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Table 10. Global Implantable Drug-Eluting Devices Revenue by Type (2019-2024) & ($ million)
Table 11. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Table 12. Global Implantable Drug-Eluting Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 14. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Table 15. Global Implantable Drug-Eluting Devices Revenue by Application (2019-2024)
Table 16. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
Table 17. Global Implantable Drug-Eluting Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Implantable Drug-Eluting Devices Sales by Company (2019-2024) & (Units)
Table 19. Global Implantable Drug-Eluting Devices Sales Market Share by Company (2019-2024)
Table 20. Global Implantable Drug-Eluting Devices Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Implantable Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
Table 22. Global Implantable Drug-Eluting Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Implantable Drug-Eluting Devices Producing Area Distribution and Sales Area
Table 24. Players Implantable Drug-Eluting Devices Products Offered
Table 25. Implantable Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Implantable Drug-Eluting Devices Sales by Geographic Region (2019-2024) & (Units)
Table 29. Global Implantable Drug-Eluting Devices Sales Market Share Geographic Region (2019-2024)
Table 30. Global Implantable Drug-Eluting Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Implantable Drug-Eluting Devices Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Implantable Drug-Eluting Devices Sales by Country/Region (2019-2024) & (Units)
Table 33. Global Implantable Drug-Eluting Devices Sales Market Share by Country/Region (2019-2024)
Table 34. Global Implantable Drug-Eluting Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Implantable Drug-Eluting Devices Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 37. Americas Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 38. Americas Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 40. Americas Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 41. Americas Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 42. APAC Implantable Drug-Eluting Devices Sales by Region (2019-2024) & (Units)
Table 43. APAC Implantable Drug-Eluting Devices Sales Market Share by Region (2019-2024)
Table 44. APAC Implantable Drug-Eluting Devices Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Implantable Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
Table 46. APAC Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 47. APAC Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 48. Europe Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 49. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 50. Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 52. Europe Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 53. Europe Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 54. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 55. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 59. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Implantable Drug-Eluting Devices
Table 61. Key Market Challenges & Risks of Implantable Drug-Eluting Devices
Table 62. Key Industry Trends of Implantable Drug-Eluting Devices
Table 63. Implantable Drug-Eluting Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Implantable Drug-Eluting Devices Distributors List
Table 66. Implantable Drug-Eluting Devices Customer List
Table 67. Global Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (Units)
Table 68. Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 70. Americas Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (Units)
Table 72. APAC Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 74. Europe Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 76. Middle East & Africa Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Implantable Drug-Eluting Devices Sales Forecast by Type (2025-2030) & (Units)
Table 78. Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Implantable Drug-Eluting Devices Sales Forecast by Application (2025-2030) & (Units)
Table 80. Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Pfizer Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 83. Pfizer Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. Medtronic Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Medtronic Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 88. Medtronic Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Medtronic Main Business
Table 90. Medtronic Latest Developments
Table 91. Merck Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 93. Merck Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Bayer AG Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. Bayer AG Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 98. Bayer AG Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bayer AG Main Business
Table 100. Bayer AG Latest Developments
Table 101. Johnson & Johnson Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 103. Johnson & Johnson Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Abbott Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. Abbott Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 108. Abbott Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Abbott Main Business
Table 110. Abbott Latest Developments
Table 111. Surmodics Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Surmodics Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 113. Surmodics Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Surmodics Main Business
Table 115. Surmodics Latest Developments
Table 116. Boston Scientific Corporation Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 118. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Boston Scientific Corporation Main Business
Table 120. Boston Scientific Corporation Latest Developments
Table 121. Titan Pharmaceuticals, Inc. Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 123. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Titan Pharmaceuticals, Inc. Main Business
Table 125. Titan Pharmaceuticals, Inc. Latest Developments
Table 126. BIOTRONIK Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. BIOTRONIK Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 128. BIOTRONIK Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. BIOTRONIK Main Business
Table 130. BIOTRONIK Latest Developments
Table 131. Allergan Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 132. Allergan Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 133. Allergan Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Allergan Main Business
Table 135. Allergan Latest Developments
Table 136. Bausch & Lomb Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 137. Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 138. Bausch & Lomb Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Bausch & Lomb Main Business
Table 140. Bausch & Lomb Latest Developments
Table 141. REVA Medical Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 142. REVA Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 143. REVA Medical Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. REVA Medical Main Business
Table 145. REVA Medical Latest Developments
Table 146. MicroPort Medical Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 147. MicroPort Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 148. MicroPort Medical Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. MicroPort Medical Main Business
Table 150. MicroPort Medical Latest Developments
Table 1. Implantable Drug-Eluting Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Implantable Drug-Eluting Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Implantable Drug Infusion Pumps
Table 4. Major Players of Intraocular Drug-Eluting Devices
Table 5. Major Players of Contraceptive Drug-Eluting Devices
Table 6. Major Players of Drug-Eluting Stents
Table 7. Major Players of Others
Table 8. Global Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 9. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Table 10. Global Implantable Drug-Eluting Devices Revenue by Type (2019-2024) & ($ million)
Table 11. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Table 12. Global Implantable Drug-Eluting Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 14. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Table 15. Global Implantable Drug-Eluting Devices Revenue by Application (2019-2024)
Table 16. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
Table 17. Global Implantable Drug-Eluting Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Implantable Drug-Eluting Devices Sales by Company (2019-2024) & (Units)
Table 19. Global Implantable Drug-Eluting Devices Sales Market Share by Company (2019-2024)
Table 20. Global Implantable Drug-Eluting Devices Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Implantable Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
Table 22. Global Implantable Drug-Eluting Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Implantable Drug-Eluting Devices Producing Area Distribution and Sales Area
Table 24. Players Implantable Drug-Eluting Devices Products Offered
Table 25. Implantable Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Implantable Drug-Eluting Devices Sales by Geographic Region (2019-2024) & (Units)
Table 29. Global Implantable Drug-Eluting Devices Sales Market Share Geographic Region (2019-2024)
Table 30. Global Implantable Drug-Eluting Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Implantable Drug-Eluting Devices Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Implantable Drug-Eluting Devices Sales by Country/Region (2019-2024) & (Units)
Table 33. Global Implantable Drug-Eluting Devices Sales Market Share by Country/Region (2019-2024)
Table 34. Global Implantable Drug-Eluting Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Implantable Drug-Eluting Devices Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 37. Americas Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 38. Americas Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 40. Americas Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 41. Americas Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 42. APAC Implantable Drug-Eluting Devices Sales by Region (2019-2024) & (Units)
Table 43. APAC Implantable Drug-Eluting Devices Sales Market Share by Region (2019-2024)
Table 44. APAC Implantable Drug-Eluting Devices Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Implantable Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
Table 46. APAC Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 47. APAC Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 48. Europe Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 49. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 50. Europe Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 52. Europe Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 53. Europe Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 54. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2019-2024) & (Units)
Table 55. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2019-2024) & (Units)
Table 59. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2019-2024) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Implantable Drug-Eluting Devices
Table 61. Key Market Challenges & Risks of Implantable Drug-Eluting Devices
Table 62. Key Industry Trends of Implantable Drug-Eluting Devices
Table 63. Implantable Drug-Eluting Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Implantable Drug-Eluting Devices Distributors List
Table 66. Implantable Drug-Eluting Devices Customer List
Table 67. Global Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (Units)
Table 68. Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 70. Americas Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (Units)
Table 72. APAC Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 74. Europe Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Implantable Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (Units)
Table 76. Middle East & Africa Implantable Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Implantable Drug-Eluting Devices Sales Forecast by Type (2025-2030) & (Units)
Table 78. Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Implantable Drug-Eluting Devices Sales Forecast by Application (2025-2030) & (Units)
Table 80. Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Pfizer Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 83. Pfizer Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. Medtronic Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Medtronic Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 88. Medtronic Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Medtronic Main Business
Table 90. Medtronic Latest Developments
Table 91. Merck Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 93. Merck Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Bayer AG Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. Bayer AG Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 98. Bayer AG Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bayer AG Main Business
Table 100. Bayer AG Latest Developments
Table 101. Johnson & Johnson Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 103. Johnson & Johnson Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Abbott Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. Abbott Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 108. Abbott Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Abbott Main Business
Table 110. Abbott Latest Developments
Table 111. Surmodics Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Surmodics Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 113. Surmodics Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Surmodics Main Business
Table 115. Surmodics Latest Developments
Table 116. Boston Scientific Corporation Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Corporation Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 118. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Boston Scientific Corporation Main Business
Table 120. Boston Scientific Corporation Latest Developments
Table 121. Titan Pharmaceuticals, Inc. Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 123. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Titan Pharmaceuticals, Inc. Main Business
Table 125. Titan Pharmaceuticals, Inc. Latest Developments
Table 126. BIOTRONIK Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. BIOTRONIK Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 128. BIOTRONIK Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. BIOTRONIK Main Business
Table 130. BIOTRONIK Latest Developments
Table 131. Allergan Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 132. Allergan Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 133. Allergan Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Allergan Main Business
Table 135. Allergan Latest Developments
Table 136. Bausch & Lomb Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 137. Bausch & Lomb Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 138. Bausch & Lomb Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Bausch & Lomb Main Business
Table 140. Bausch & Lomb Latest Developments
Table 141. REVA Medical Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 142. REVA Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 143. REVA Medical Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. REVA Medical Main Business
Table 145. REVA Medical Latest Developments
Table 146. MicroPort Medical Basic Information, Implantable Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 147. MicroPort Medical Implantable Drug-Eluting Devices Product Portfolios and Specifications
Table 148. MicroPort Medical Implantable Drug-Eluting Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. MicroPort Medical Main Business
Table 150. MicroPort Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Implantable Drug-Eluting Devices
Figure 2. Implantable Drug-Eluting Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Drug-Eluting Devices Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Implantable Drug-Eluting Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Implantable Drug-Eluting Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Implantable Drug Infusion Pumps
Figure 10. Product Picture of Intraocular Drug-Eluting Devices
Figure 11. Product Picture of Contraceptive Drug-Eluting Devices
Figure 12. Product Picture of Drug-Eluting Stents
Figure 13. Product Picture of Others
Figure 14. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2023
Figure 15. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Figure 16. Implantable Drug-Eluting Devices Consumed in Diabetes
Figure 17. Global Implantable Drug-Eluting Devices Market: Diabetes (2019-2024) & (Units)
Figure 18. Implantable Drug-Eluting Devices Consumed in Contraception
Figure 19. Global Implantable Drug-Eluting Devices Market: Contraception (2019-2024) & (Units)
Figure 20. Implantable Drug-Eluting Devices Consumed in HIV/AIDS Prevention
Figure 21. Global Implantable Drug-Eluting Devices Market: HIV/AIDS Prevention (2019-2024) & (Units)
Figure 22. Implantable Drug-Eluting Devices Consumed in Chronic Pain Management
Figure 23. Global Implantable Drug-Eluting Devices Market: Chronic Pain Management (2019-2024) & (Units)
Figure 24. Implantable Drug-Eluting Devices Consumed in Cardiovascular
Figure 25. Global Implantable Drug-Eluting Devices Market: Cardiovascular (2019-2024) & (Units)
Figure 26. Implantable Drug-Eluting Devices Consumed in Ophthalmology
Figure 27. Global Implantable Drug-Eluting Devices Market: Ophthalmology (2019-2024) & (Units)
Figure 28. Implantable Drug-Eluting Devices Consumed in Oncology
Figure 29. Global Implantable Drug-Eluting Devices Market: Oncology (2019-2024) & (Units)
Figure 30. Implantable Drug-Eluting Devices Consumed in Others
Figure 31. Global Implantable Drug-Eluting Devices Market: Others (2019-2024) & (Units)
Figure 32. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2023)
Figure 33. Global Implantable Drug-Eluting Devices Revenue Market Share by Application in 2023
Figure 34. Implantable Drug-Eluting Devices Sales Market by Company in 2023 (Units)
Figure 35. Global Implantable Drug-Eluting Devices Sales Market Share by Company in 2023
Figure 36. Implantable Drug-Eluting Devices Revenue Market by Company in 2023 ($ Million)
Figure 37. Global Implantable Drug-Eluting Devices Revenue Market Share by Company in 2023
Figure 38. Global Implantable Drug-Eluting Devices Sales Market Share by Geographic Region (2019-2024)
Figure 39. Global Implantable Drug-Eluting Devices Revenue Market Share by Geographic Region in 2023
Figure 40. Americas Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 41. Americas Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 42. APAC Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 43. APAC Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 44. Europe Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 45. Europe Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 46. Middle East & Africa Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 47. Middle East & Africa Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 48. Americas Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 49. Americas Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 50. Americas Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 51. Americas Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 52. United States Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 53. Canada Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 54. Mexico Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 55. Brazil Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 56. APAC Implantable Drug-Eluting Devices Sales Market Share by Region in 2023
Figure 57. APAC Implantable Drug-Eluting Devices Revenue Market Share by Regions in 2023
Figure 58. APAC Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 59. APAC Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 60. China Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Japan Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. South Korea Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 63. Southeast Asia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 64. India Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 65. Australia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. China Taiwan Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Europe Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 68. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 69. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 70. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 71. Germany Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 72. France Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 73. UK Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 74. Italy Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 75. Russia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 76. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 77. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 78. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 79. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 80. Egypt Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 81. South Africa Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 82. Israel Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 83. Turkey Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 84. GCC Country Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 85. Manufacturing Cost Structure Analysis of Implantable Drug-Eluting Devices in 2023
Figure 86. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 87. Industry Chain Structure of Implantable Drug-Eluting Devices
Figure 88. Channels of Distribution
Figure 89. Global Implantable Drug-Eluting Devices Sales Market Forecast by Region (2025-2030)
Figure 90. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 91. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Type (2025-2030)
Figure 92. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 93. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Application (2025-2030)
Figure 94. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Implantable Drug-Eluting Devices
Figure 2. Implantable Drug-Eluting Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Drug-Eluting Devices Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Implantable Drug-Eluting Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Implantable Drug-Eluting Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Implantable Drug Infusion Pumps
Figure 10. Product Picture of Intraocular Drug-Eluting Devices
Figure 11. Product Picture of Contraceptive Drug-Eluting Devices
Figure 12. Product Picture of Drug-Eluting Stents
Figure 13. Product Picture of Others
Figure 14. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2023
Figure 15. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Figure 16. Implantable Drug-Eluting Devices Consumed in Diabetes
Figure 17. Global Implantable Drug-Eluting Devices Market: Diabetes (2019-2024) & (Units)
Figure 18. Implantable Drug-Eluting Devices Consumed in Contraception
Figure 19. Global Implantable Drug-Eluting Devices Market: Contraception (2019-2024) & (Units)
Figure 20. Implantable Drug-Eluting Devices Consumed in HIV/AIDS Prevention
Figure 21. Global Implantable Drug-Eluting Devices Market: HIV/AIDS Prevention (2019-2024) & (Units)
Figure 22. Implantable Drug-Eluting Devices Consumed in Chronic Pain Management
Figure 23. Global Implantable Drug-Eluting Devices Market: Chronic Pain Management (2019-2024) & (Units)
Figure 24. Implantable Drug-Eluting Devices Consumed in Cardiovascular
Figure 25. Global Implantable Drug-Eluting Devices Market: Cardiovascular (2019-2024) & (Units)
Figure 26. Implantable Drug-Eluting Devices Consumed in Ophthalmology
Figure 27. Global Implantable Drug-Eluting Devices Market: Ophthalmology (2019-2024) & (Units)
Figure 28. Implantable Drug-Eluting Devices Consumed in Oncology
Figure 29. Global Implantable Drug-Eluting Devices Market: Oncology (2019-2024) & (Units)
Figure 30. Implantable Drug-Eluting Devices Consumed in Others
Figure 31. Global Implantable Drug-Eluting Devices Market: Others (2019-2024) & (Units)
Figure 32. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2023)
Figure 33. Global Implantable Drug-Eluting Devices Revenue Market Share by Application in 2023
Figure 34. Implantable Drug-Eluting Devices Sales Market by Company in 2023 (Units)
Figure 35. Global Implantable Drug-Eluting Devices Sales Market Share by Company in 2023
Figure 36. Implantable Drug-Eluting Devices Revenue Market by Company in 2023 ($ Million)
Figure 37. Global Implantable Drug-Eluting Devices Revenue Market Share by Company in 2023
Figure 38. Global Implantable Drug-Eluting Devices Sales Market Share by Geographic Region (2019-2024)
Figure 39. Global Implantable Drug-Eluting Devices Revenue Market Share by Geographic Region in 2023
Figure 40. Americas Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 41. Americas Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 42. APAC Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 43. APAC Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 44. Europe Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 45. Europe Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 46. Middle East & Africa Implantable Drug-Eluting Devices Sales 2019-2024 (Units)
Figure 47. Middle East & Africa Implantable Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 48. Americas Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 49. Americas Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 50. Americas Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 51. Americas Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 52. United States Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 53. Canada Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 54. Mexico Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 55. Brazil Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 56. APAC Implantable Drug-Eluting Devices Sales Market Share by Region in 2023
Figure 57. APAC Implantable Drug-Eluting Devices Revenue Market Share by Regions in 2023
Figure 58. APAC Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 59. APAC Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 60. China Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Japan Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. South Korea Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 63. Southeast Asia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 64. India Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 65. Australia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. China Taiwan Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Europe Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 68. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 69. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 70. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 71. Germany Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 72. France Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 73. UK Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 74. Italy Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 75. Russia Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 76. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 77. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 78. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 79. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 80. Egypt Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 81. South Africa Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 82. Israel Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 83. Turkey Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 84. GCC Country Implantable Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 85. Manufacturing Cost Structure Analysis of Implantable Drug-Eluting Devices in 2023
Figure 86. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 87. Industry Chain Structure of Implantable Drug-Eluting Devices
Figure 88. Channels of Distribution
Figure 89. Global Implantable Drug-Eluting Devices Sales Market Forecast by Region (2025-2030)
Figure 90. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 91. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Type (2025-2030)
Figure 92. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 93. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Application (2025-2030)
Figure 94. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Palmar Resting Splints Market Growth 2024-2030
US$ 3,660.00
March 2024
133 pages
Global Amniotic Hooks Market Growth 2024-2030
US$ 3,660.00
September 2024
98 pages
Global Advanced Wound Dressings Market Growth 2025-2031
US$ 3,660.00
January 2025
146 pages
Global Retroperitoneal Fibrosis Treatment Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Flexible Cystoscope Market Growth 2023-2029
US$ 3,660.00
February 2023
109 pages
